Miruna Sasu, Former Johnson & Johnson Executive, Takes the Helm at COTA, Inc. as President and CEO
March 24th 2022Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based cancer care.
Insilico Medicine Announces Strategic Collaboration with EQRx
March 24th 2022The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices.
Q&A With Ignacio Medina, founder, Zetta Genomics
March 24th 2022Genomic data is transforming precision medicine—but progress depends on it being easily available where it’s needed. Pharmaceutical Executive speaks to Ignacio Medina, founder of Cambridge University spinout Zetta Genomics, to see how next-generation open-source data technologies accelerate discovery in the lab and patient benefit in the clinic.
Q&A With Aoife Brennan, president and CEO of Synlogic, Inc.
March 16th 2022Brennan describes what her career journey in pharma has looked like as a woman, and what she feels can be done to improve opportunities for other females in pharma. She also talks about how advocacy and commitment can similarly be applied to improve the rare disease space.